Abstract:Background: Hypoxia-inducible factor-1α (HIF-1α) induces the expression of glycolysis-related genes, which plays a direct and key role in Warburg effect. In a recent study, honokiol (HNK) was identified as one of the potential agents that inhibited the HIF-1α signaling pathway. Because the HIF- 1α pathway is closely associated with glycolysis, we investigated whether HNK inhibited HIF-1α-mediated glycolysis. Methods: The effects of HNK on HIF-1α-mediated glycolysis and other glycolysis-related genes’ expressions, cancer cells apoptosis and tumor growth were studied in various human breast cancer models in vitro and in vivo . We performed the following tests: extracellular acidification and oxygen consumption rate assays, glucose uptake, lactate, and ATP assays for testing glycolysis; WST-1 assay for investigating cell viability; colony formation assay for determining clonogenicity; flow cytometry for assessing cell apoptosis; qPCR and Western blot for determining the expression of HIF-1α, GLUT1, HK2 and PDK1. The mechanisms of which HNK functions as a direct inhibitor of HIF-1α were verified through the ubiquitination assay, the Co-IP assay, and the cycloheximide (CHX) pulse-chase assay. Results: HNK increased the oxygen consumption rate while decreased the extracellular acidification rate in breast cancer cells; it further reduced glucose uptake, lactic acid production and ATP production in cancer cells. The inhibitory effect of HNK on glycolysis is HIF-1α-dependent. HNK also downregulated the expression of HIF-1α and its downstream regulators, including GLUT1, HK2 and PDK1. A mechanistic study demonstrated that HNK enhanced the self-ubiquitination of HIF-1α by recruiting two E3 ubiquitin ligases (UFL1 and BRE1B). In vitro, HNK inhibited cell proliferation and clonogenicity, as well as induced apoptosis of cancer cells. These effects were also HIF1α-dependent. In vivo , HNK inhibited tumor growth and HIF-1α-mediated glycolysis. Conclusion: HNK has an inhibitory effect on HIF-1α-mediated glycolysis in human breast cancer. Our research revealed a new mechanism of HNK as an anti-cancer drug, thus representing a novel strategy to improve the prognosis of cancer.

Honokiol: an Effective Inhibitor of High-Glucose-Induced Upregulation of Inflammatory Cytokine Production in Human Renal Mesangial Cells

Inhibitory Effects of Honokiol on Lipopolysaccharide-Induced Cellular Responses and Signaling Events in Human Renal Mesangial Cells

Honokiol: an effective inhibitor of tumor necrosis factor-α-induced up-regulation of inflammatory cytokine and chemokine production in human synovial fibroblasts

Honokiol inhibits carotid artery atherosclerotic plaque formation by suppressing inflammation and oxidative stress

Inhibition of Inflammatory Factors by Parthenolide in Human Renal Mesangial Cells under Hyperglycemic Condition

Protective effects of honokiol against oxidative stress-induced apoptotic signaling in mouse podocytes treated with H2O2.

Honokiol Up-Regulates Prostacyclin Synthease Protein Expression and Inhibits Endothelial Cell Apoptosis.

Nephroprotective effects of honokiol in a high-fat diet-streptozotocin rat model of diabetic nephropathy

The glucotoxicity protecting effect of honokiol in human hepatocytes via directly activating AMPK

Honokiol Inhibits the Inflammatory Reaction During Cerebral Ischemia Reperfusion by Suppressing NF-κB Activation and Cytokine Production of Glial Cells.

Honokiol attenuates high glucose‐induced peripheral neuropathy via inhibiting ferroptosis and activating AMPK/SIRT1/PGC‐1α pathway in Schwann cells

Honokiol Augments the Anti-Cancer Effects of Oxaliplatin in Colon Cancer Cells

Honokiol Inhibits Arterial Thrombosis Through Endothelial Cell Protection and Stimulation of Prostacyclin

Beneficial Effects of Huaiqihuang on Hyperglycemia-Induced MPC5 Podocyte Dysfunction Through the Suppression of Mitochondrial Dysfunction and Endoplasmic Reticulum Stress

Effect of All-trans Retinoic Acid on High Glucose Induced-Expression of Inflammatory Factors in HK-2 Cells

Honokiol Alleviates Ulcerative Colitis by Targeting PPAR-γ–TLR4–NF-κB Signaling and Suppressing Gasdermin-D-mediated Pyroptosis in Vivo and in Vitro

Honokiol Inhibits Hespg2 Migration Via Down-Regulation Of Iqgap1 Expression Discovered By A Quantitative Pharmaceutical Proteomic Analysis

Honokiol Inhibits HIF-1α-Mediated Glycolysis to Halt Breast Cancer Growth

BML-111 Attenuates High Glucose-Induced Inflammation, Oxidative Stress and Reduces Extracellular Matrix Accumulation Via Targeting Nrf2 in Rat Glomerular Mesangial Cells

Honokiol inhibits epithelial-mesenchymal transition and hepatic fibrosis via activation of Ecadherin/GSK3β/JNK and inhibition of AKT/ERK/p38/β-catenin/TMPRSS4 signaling axis

Anti-Inflammatory Effect Of Ppar Gamma In Cultured Human Mesangial Cells